1. Current Status of Raf Kinase Inhibitor Protein (RKIP) in Lung Cancer: Behind RTK Signaling
    Ana Raquel-Cunha et al, 2019, Cells CrossRef
  2. 15-Lipoxygenase-2/15(S)-hydroxyeicosatetraenoic acid regulates cell proliferation and metastasis via the STAT3 pathway in lung adenocarcinoma
    Lin Yang et al, 2018, Prostaglandins & Other Lipid Mediators CrossRef
  3. Computational Analyses of YY1 and Its Target RKIP Reveal Their Diagnostic and Prognostic Roles in Lung Cancer
    Silvia Vivarelli et al, 2022, Cancers CrossRef
  4. Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma
    Wentao Zhang et al, 2023, Frontiers in Immunology CrossRef
  5. Inhibition of the Raf-1 kinase inhibitory protein (RKIP) by locostatin induces cell death and reduces the CXCR4-mediated migration of chronic lymphocytic leukemia cells
    Kyle Crassini et al, 2018, Leukemia & Lymphoma CrossRef
  6. Implications of RKIP protein in cancer prognosis and therapy response: A literature update
    Diana Cardoso-Carneiro et al, 2020, Prognostic and Therapeutic Applications of RKIP in Cancer CrossRef
  7. Identification of regulatory crosstalks between RKIP and BRCA1 tumor suppressors in healthy tissues and cancer (breast and ovarian): Therapeutic implications
    Martina Rama et al, 2020, Prognostic and Therapeutic Applications of RKIP in Cancer CrossRef
  8. Investigation of Marine-Derived Natural Products as Raf Kinase Inhibitory Protein (RKIP)-Binding Ligands
    Shraddha Parate et al, 2021, Marine Drugs CrossRef
  9. The RAF Kinase Inhibitor Protein (RKIP): Good as Tumour Suppressor, Bad for the Heart
    Joshua Abd Alla et al, 2022, Cells CrossRef
  10. LncRNA GATA6-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer via Repressing microRNA-543 to Up-Regulating RKIP


    Zixuan Gong et al, 2020, Cancer Management and Research CrossRef
  11. Theranostic role of RKIP in cancer
    Begum Dariya et al, 2020, Prognostic and Therapeutic Applications of RKIP in Cancer CrossRef
  12. Clinical Significance of Frequently Down-Regulated Phosphatidylethanolamine-Binding Protein-1 in Gallbladder Cancer
    Amisha Bharti et al, 2024, Digestive Diseases and Sciences CrossRef
  13. RKIP a master of regulatory pathways: Perspectives
    Khosrow Kashfi et al, 2020, Prognostic and Therapeutic Applications of RKIP in Cancer CrossRef
  14. Raf kinase inhibitor protein combined with phosphorylated extracellular signal-regulated kinase offers valuable prognosis in gastrointestinal stromal tumor
    Wen-Zhi Qu et al, 2023, World Journal of Gastroenterology CrossRef
  15. A review of RKIP promotion of tumor progression, metastasis and poor outcome in multiple solid tumor types
    Eoin Dervan et al, 2020, Prognostic and Therapeutic Applications of RKIP in Cancer CrossRef
  16. Unraveling the Post-Translational Modifications and therapeutical approach in NSCLC pathogenesis
    Pooja Gulhane et al, 2023, Translational Oncology CrossRef
  17. Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies
    Md Entaz Bahar et al, 2023, Signal Transduction and Targeted Therapy CrossRef
  18. MicroRNA-124a inhibits cell proliferation and migration in liver cancer by regulating interleukin-11
    Liedao Yu et al, 2017, Molecular Medicine Reports CrossRef
  19. RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact
    Apostolos Zaravinos et al, 2018, Cancers CrossRef
  20. RKIP as an Inflammatory and Immune System Modulator: Implications in Cancer
    null Gabriela-Freitas et al, 2019, Biomolecules CrossRef
  21. Understanding Mechanisms of RKIP Regulation to Improve the Development of New Diagnostic Tools
    Massimo Papale et al, 2022, Cancers CrossRef